Ascendis Pharma
ASND
ASND
31 hedge funds and large institutions have $416M invested in Ascendis Pharma in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
48% more capital invested
Capital invested by funds: $281M → $416M (+$135M)
41% more funds holding
Funds holding: 22 → 31 (+9)
Holders
31
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$35M | |
| 2 | +$21.3M | |
| 3 | +$15.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.9M |
| 5 |
O
OrbiMed
New York
|
+$10.7M |
Top Sellers
| 1 | -$2.26M | |
| 2 | -$1.09M | |
| 3 | -$935K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$302K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14.4K |